United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. triazolam is contraindicated in: - patients with known hypersensitivity to triazolam, any of component of triazolam tablets, or other benzodiazepines. reactions consistent with angioedema (involving the tongue, glottis, or larynx), dyspnea, and throat closing have been reported and may be fatal. - concomitant administration of strong cytochrome p450 (cyp 3a) enzyme inhibitors (e.g., ketoconazole, itraconazole, nefazodone, lopinavir, ritonavir) [ see warnings and precautions ( 5.8 ), drug interactions (7.1) ] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including triazolam, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/. risk

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. triazolam is contraindicated in: - patients with known hypersensitivity to triazolam, any of component of triazolam tablets, or other benzodiazepines. reactions consistent with angioedema (involving the tongue, glottis, or larynx), dyspnea, and throat closing have been reported and may be fatal. - concomitant administration of strong cytochrome p450 (cyp 3a) enzyme inhibitors (e.g., ketoconazole, itraconazole, nefazodone, lopinavir, ritonavir) [ see warnings and precautions (5.8), drug interactions (7.1) ] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to triazolam during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for other psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermed

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. triazolam is contraindicated in: - patients with known hypersensitivity to triazolam, any of component of triazolam, or other benzodiazepines. reactions consistent with angioedema (involving the tongue, glottis, or larynx), dyspnea, and throat closing have been reported and may be fatal. - concomitant administration of strong cytochrome p450 (cyp 3a) enzyme inhibitors (e.g., ketoconazole, itraconazole, nefazodone, lopinavir, ritonavir) [see warnings and precautions (5.8), drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including triazolam, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/. risk summ

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - fosaprepitant dimeglumine 245.3mg eqv fosaprepitant - injection, powder, lyophilized, for solution - 150.0 mg - fosaprepitant dimeglumine 245.3mg eqv fosaprepitant 150.0 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mercury pharma group ltd - clarithromycin - powder for solution for infusion - 500mg

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - clarithromycin 500mg - powder for infusion concentrate - 500 mg - active: clarithromycin 500mg excipient: lactobionic acid - clarithromycin intravenous infusion is indicated whenever parenteral therapy is required for treatment of sensitive microorganisms in the following conditions: · upper respiratory tract infections · lower respiratory tract infections · skin and soft tissue infections

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - erythromycin lactobionate - powder for solution for infusion - 1gram

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - amiodarone hydrochloride - concentrate for solution for infusion - 150mg/3 millilitre(s) - antiarrhythmics, class iii; amiodarone

Malta - English - Medicines Authority

as kalceks krustpils iela 71e, riga, lv-1057,, latvia - morphine hydrochloride - solution for infusion or injection - morphine hydrochloride 20 mg - analgesics

Malta - English - Medicines Authority

as kalceks krustpils iela 71e, riga, lv-1057,, latvia - morphine hydrochloride - solution for infusion or injection - morphine hydrochloride 100 mg - analgesics